Trimethoprim and tetracycline inhibit airway epithelial sodium absorption

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 1, 1996, Pages 18-23

  Middleton, Peter G ^a   Geddes, Duncan M ^a   Alton, Eric W F W ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; AMPICILLIN; CEFTAZIDIME; CHLORAMPHENICOL DERIVATIVE; COLISTIN; ERYTHROMYCIN; GENTAMICIN; SODIUM CHANNEL; SULFAMETHOXAZOLE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM;

ANIMAL TISSUE; ARTICLE; BIOENERGY; CYSTIC FIBROSIS; DRUG INHIBITION; ION TRANSPORT; LUNG FUNCTION; NONHUMAN; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SHEEP; SODIUM ABSORPTION; TRACHEA MUCOSA;

EID: 0030017198     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.1.8680677     Document Type: Article

References (21)

1. Quinton, P. M. 1990. Cystic fibrosis;a disease in electrolyte transport. FASEB J. 4:2709-2717.
2. Knowles, M. R., M. J. Stutts, A. Spock, N. Fischer, J. T. Gatzy, and R. C. Boucher. 1983. Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science 221:1067-1070.
3. Hudson, M. E., A. R. L. Penketh, and J. C. Batten. 1981. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet ii:1137-1139.
4. Tamaoki, J., K. Isono, N. Sakai, T. Kanemura, and K. Konno. 1992. Erythromycin inhibits CI secretion across canine tracheal epithelial cells. Eur. Respir. J. 5:234-238.
5. Steel, D. M., A. Graham, D. M. Geddes, and E. W. F. W. Alton. 1994. Characterization and comparison of ion transport across sheep and human airway epithelium. Epith. Cell Biol. 3:24-31.
6. Graham, A., D. M. Steel, E. W. F. W. Alton, and D. M. Geddes. 1992. Second-messenger regulation of sodium transport in mammalian airway epithelia. J. Physiol. 453:475-491.
7. Middleton, P. G., N. J. Caplen, X. Gao, L. Huang, H. Gaya, D. M. Geddes, and E. W. F. W. Alton. 1994. Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growth. Eur. Respir. J. 7:442-445.
8. Middleton, P. G., D. M. Geddes, and E. W. F. W. Alton. 1994. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur. Respir. J. 7:2050-2056.
9. Knowles, M., G. Murray, J. Shallal, F. Askin, V. Ranga, J. Gatzy, and R. Boucher. 1984. Bioelectric properties and ion flow across excised human bronchi. J. Appl. Physiol. 56:868-877.
10. Choi, M. J., P. C. Fernandez, A. Patnaik, B. Coupaye-Gerard, D. D'Andrea, H. Szerlip, and T. R. Kleyman. 1993. Trimethoprim-induced hyperkalemia in a patient with AIDS. N. Engl. J. Med. 328:703-706.
11. + channels in A6 distal nephron cells. Kidney Int. 45:1070-1076.
12. Fonseca, P. D., T. F. Moura, and K. T. G. Ferreira. 1991. The effect of trimethoprim on sodium transport across the frog skin epithelium. Eur. J. Pharmacol. 207:337-343.
13. Köhler, D., E. App, M. Schmitz-Schumann, G. Wurtemberger, and H. Matthys. 1986. Inhalation of amiloride improves the mucociliary and the cough clearance in patients with cystic fibrosis. Eur. J. Respir. Dis. 69(Suppl. 146):319-326.
14. App, E. M., M. King, R. Helfesrieder, D. Köhler, and H. Matthys. 1990. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy. Am. Rev. Respir. Dis. 141:605-612.
15. Knowles, M. R., N. L. Church, W. E. Waltner, J. R. Yankaskas, P. Gilligan, M. King, L. J. Edwards, R. W. Helms, and R. C. Boucher. 1990. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N. Engl. J. Med. 322:1189-1194.
16. Middleton, P. G., D. M. Geddes, and E. W. F. W. Alton. 1993. Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects. Thorax 48:812-816.
17. Graham, A., A. Hasani, E. W. F. W. Alton, G. P. Martin, C. Marriott, M. E. Hodson, S. W. Clarke, and D. M. Geddes. 1993. No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur. Respir. J. 6:1243-1248.
18. Cohn, R. C. and S. C. Aronoff. 1989. The effect of sodium on amiloridelobramycin synergy in Pseudomonas cepacia. J. Lab. Clin. Med. 114: 724-727.
19. Lisker, A., P. Gilligan, K. Wait, and M. Knowles. 1987. In vitro activity of amiloride against bacteria isolated from patients with cystic fibrosis. Pediatr. Pulmonol. 3(Suppl. 1):126.
20. Mentz, W. M., J. B. Brown, M. Friedman, M. J. Stutts, J. T. Gatzy, and R. C. Boucher. 1986. Deposition, clearance, and effects of aerosolized amiloride in sheep airways. Am. Rev. Respir. Dis. 134:938-943.
21. Waltner, W. E., N. L. Church, J. T. Gatzy, R. C. Boucher, and M. R. Knowles. 1987. Deposition, pharmacokinetics, and toxicity of amiloride aerosol in normal and cystic fibrosis (CF) subjects (abstract). Am. Rev. Respir. Dis. 135:A288.